A vaccine in development would be the first proactive treatment for overdose and fentanyl addiction, if approved. A vaccine ...

Concurrently, low state immunization levels pose a significant and immediate risk, particularly for measles, which is ...

RNA-based immunizing agents have enriched the repertoire of technologies used for vaccine development. An analysis of the active clinical trials in early Phase I and Phase I during the year of 2023 ...

STOCKHOLM, Sweden, December 22, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company ...

Recombinant protein vaccines, which are obtained by conventional genetic engineering, are based on the proteins of target pathogens that can activate our immune systems. Unlike other types of vaccines ...

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Vaccine Development Companies Landscape: Competitive Landscape, Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price ...

COVID-19 brought unprecedented public attention to the development, regulation, and timeline for products that prevent deadly infections, potentially heralding an era of vaccine innovation marked by ...

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

Natal (UKZN) is among key institutions under investigation by the Special Investigating Unit (SIU) over alleged ...